Трансплантология (Москва) (Sep 2020)

Long-term therapy of Kaposi’s sarcoma with the use of prospidium chloride and mTOR receptor inhibitors in а patient after kidney transplantation

  • E. V. Parabina,
  • B. I. Yaremin,
  • M. M. Kaabak

DOI
https://doi.org/10.23873/2074-0506-2020-12-3-213-219
Journal volume & issue
Vol. 12, no. 3
pp. 213 – 219

Abstract

Read online

A case of a long-term management of a patient with Kaposi’s sarcoma developed as presumably related to a “standard” immunosuppressive therapy after kidney transplantation has been described. Immunosuppressive therapy conversion to mTOR receptor inhibitors and administering chemotherapy with prospidium chloride allowed for a long-term remission of the disease and a satisfactory clinical outcome.

Keywords